Elena Maria Elli

Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

Roberto Marchioli, Guido Finazzi, Giorgina Specchia et al. · New England Journal of Medicine · 2012 · 791 citations · Full text

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

Valerio De Stefano, Tommaso Zà, E. Rossi et al. · Haematologica · 2008 · 352 citations · Full text

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 164 citations

Hematological Malignancy, Bone Marrow Failure, Momelotinib Versus Danazol +6

Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis

Francesca Palandri, Massimo Breccia, Massimiliano Bonifacio et al. · Cancer · 2019 · 144 citations · Full text

Hydroxyurea‐related toxicity in 3,411 patients with Ph'‐negative MPN

Elisabetta Antonioli, Paola Guglielmelli, Lisa Pieri et al. · American Journal of Hematology · 2012 · 133 citations · Full text

Hematological Malignancy, Oncology, Medicine +15